Lorazepam

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

Synonyms / Brand Names:Almazine, Alzapam, Anxiedin, Aplacassee, Ativan, Bonatranquan, Delormetazepam, Emotival, Idalprem, Lorabenz, Lorax, Loraz, Lorazepam Intensol, Lorsilan, Pro Dorm, Psicopax, Punktyl, Quait, Securit, Sedatival, Sedazin, Somagerol, Tavor, Temesta, Wypax

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884

Dosing and Administration

Ativan (lorazepam) is administered orally. For optimal results, dose, frequency of administration, and duration of therapy should be individualized according to patient response. The usual range is 2 to 6 mg/day given in divided doses, the largest dose being taken before bedtime, but the daily dosage may vary from 1 to 10 mg/day. For anxiety, most patients require an initial dose of 2 to 3 mg/day given b.i.d. or t.i.d. For insomnia due to anxiety or transient situational stress, a single daily dose of 2 to 4 mg may be given, usually at bedtime. For elderly or debilitated patients, an initial dosage of 1 to 2 mg/day in divided doses is recommended, to be adjusted as needed and tolerated.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Lorazepam

Return to top

Publication Resources

Most Recent Articles on Lorazepam

Review Articles on Lorazepam

Articles on Lorazepam in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Lorazepam

Return to top

Trial Resources

Ongoing Trials with Lorazepam at Clinical Trials.gov

Trial Results with Lorazepam

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Lorazepam

Cochrane Collaboration on Lorazepam

Cost Effectiveness of Lorazepam

Return to top

Media Resources

Powerpoint Slides on Lorazepam

Images of Lorazepam

Podcasts & MP3s on Lorazepam

Videos on Lorazepam

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Lorazepam

Discussion Groups on Lorazepam

Patient Handouts on Lorazepam

Blogs on Lorazepam

Lorazepam in the News

Lorazepam in the Marketplace

Return to top

International Resources

Lorazepam en Español

Return to top


The content of this page is taken from the FDA package insert for this drug and should not be edited.

Personal tools